A patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has:
(1) A terminal illness that is attested to by the patient’s treating health care provider;

Terms Used In Kentucky Statutes 217.5403

  • Device: means any instrument or contrivance other than a firearm which is intended for trapping, destroying, repelling, or mitigating any pest or any other form of plant or animal life other than man and other bacteria, virus, or other microorganisms on or in living man or other living animals. See Kentucky Statutes 217.544
  • Treatment: when used in a criminal justice context, means targeted interventions
    that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010

(2) Considered all other treatment options currently approved by the United States Food and Drug Administration;
(3) Received a recommendation from the patient’s treating health care provider for an investigational drug, biological product, or device;
(4) Given written informed consent for the use of the investigational drug, biological product, or device; and
(5) Documentation from the treating health care provider that the patient meets the requirements of this section.
Effective: June 29, 2017
History: Created 2017 Ky. Acts ch. 65, sec. 3, effective June 29, 2017.
Formerly codified as KRS § 217.5405.